Piperidine compounds having multimodal activity against pain

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9902711
SERIAL NO

15106398

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opiod receptor and more particularly to piperidene compounds having this pharmacological activity, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ESTEVE PHARMACEUTICALS S APASSEIG DE LA ZONA FRANCA 109 4ª PLANTA TORRE ESTEVE BARCELONA 08038

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Almansa-Rosales, Carmen Barcelona, ES 59 26
Ayet, Galcera Eva Maria Barcelona, ES 1 1
Cuevas-Cordobés, Félix Valdemoro, ES 11 1
Garcia, Lopez Monica Barcelona, ES 12 12
Serafini, Cabanes Maria Teresa Sabadell, ES 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 27, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 27, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00